ATR
AptarGroup, Inc.
NYSE · USHealthcareMedical - Instruments & Supplies
$129.91-2.04%
Price as of Jul 20, 2026
ATR financials
AptarGroup, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $3.8B | $3.6B | $3.5B | $3.3B |
| Cost of revenue | $2.7B | $2.2B | $2.2B | $2.2B |
| Gross profit | $1.1B | $1.4B | $1.3B | $1.2B |
| Operating expenses | $605.0M | $859.0M | $859.4M | $784.6M |
| Operating income | $512.3M | $496.5M | $404.0M | $379.3M |
| Net income | $392.8M | $374.5M | $284.5M | $239.3M |
| EBITDA | $831.5M | $777.4M | $663.8M | $609.4M |
| Basic EPS | $5.97 | $5.65 | $4.34 | $3.66 |
| Diluted EPS | $5.88 | $5.53 | $4.25 | $3.59 |
| Balance sheet | ||||
| Cash & equivalents | $402.4M | $223.8M | $223.6M | $141.7M |
| Total assets | $5.3B | $4.4B | $4.5B | $4.2B |
| Total liabilities | $2.5B | $1.9B | $2.1B | $2.1B |
| Stockholders’ equity | $2.7B | $2.5B | $2.3B | $2.1B |
| Total debt | $1.5B | $1.1B | $1.2B | $1.2B |
| Net debt | $1.1B | $852.2M | $961.0M | $1.1B |
| Cash flow | ||||
| Operating cash flow | $570.0M | $643.4M | $575.2M | $478.6M |
| Capital expenditure | -$270.4M | -$294.2M | -$318.4M | -$315.6M |
| Free cash flow | $299.6M | $349.2M | $256.8M | $163.0M |
| Dividends paid | -$120.8M | -$114.1M | -$103.7M | -$99.5M |
| Share repurchases | -$365.0M | -$68.6M | -$47.6M | -$92.1M |